The purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood…

Pancreatic Cancer, Advanced or Metastatic

~Estimated

~$10 – $750

University of Maryland, BaltimoreNCT07528430

Phase 1

A Multi-Center, Open Label, Phase 1/2 Study of CP-383, in Patients With Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. Th…

Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more

~Estimated

~$10 – $8,750

Tasca TherapeuticsNCT07030257